PDFs und wei­te­re Infor­ma­tio­nen zum Down­load fin­den Sie hier.

CE Doku­ment COVID-19 Ag
CE DoC_BIOCREDIT COVID-19 Ag.pdf
PDF-Doku­ment [12.3 KB]

EU Pro­dukt Zer­ti­fi­kat COVID-19 Ag
Rapi­GEN Cer­ti­fi­ca­te of EU pro­duct notifi[…]
PDF-Doku­ment [382.0 KB]

BIOCREDIT COVID-19 Ag Gebrauchsanleitung
GebrauchsanleitungAntiGen.pdf
PDF-Doku­ment [385.7 KB]

BIOCREDIT COVID-19 Ag Mate­ri­al Safe­ty Data Sheet
SafetySheetAntiGen.pdf
PDF-Doku­ment [635 KB]


CE Doku­ment COVID-19 lgG lgM
CE DoC_BIOCREDIT COVID-19 IgG+IgM Duo.pdf
PDF-Doku­ment [12.6 KB]

EU Pro­dukt Zer­ti­fi­kat COVID-19 lgG/lgM Duo
Rapi­GEN Cer­ti­fi­ca­te of EU pro­duct notification.pdf
PDF-Doku­ment [382.0 KB]

BIOCREDIT COVID-19 lgG/lgM Gebrauchsanleitung
GebrauchsanleitungAntiKoerper.pdf
PDF-Doku­ment [437.1 KB]


Cer­ti­fi­ca­te of EU pro­duct noti­fi­ca­ti­on COVID-19 Ag
GCMS_GENEDIA W COVID-19 Ag_EU Representative.pdf
PDF-Doku­ment [273 KB]

GCMS Gene­dia W Brochu­re COVID-19 Ag
GCMS_GENEDIA W COVID-19 Ag_Brochure.pdf
PDF-Doku­ment [1.6 MB]

GCMS Gene­dia W COVID-19 Ag Gebrauchsanleitung
GCMS_GENEDIA W COVID-19 Ag_IFU_EN_.pdf
PDF-Doku­ment [806 KB]

GCMS Gene­dia W COVID-19 Ag Dedi­ca­ti­on of Conformity
GCMS_GENEDIA W COVID-19 Ag_Declaration of Conformity.pdf
PDF-Doku­ment [179 KB]

GCMS Gene­dia W COVID-19 Ag Cli­ni­cal Per­for­mance Report
GCMS_GENEDIA W COVID-19 Ag_Clinical Per­for­mance Eva­lua­ti­on Report.pdf
PDF-Doku­ment [461 KB]


Novel Coro­na­vi­rus (SARS-Cov‑2) Anti­gen Schnell­test (Spei­chel) Gebrauchs­an­wei­sung (DE)
Novel Coro­na­vi­rus (SARS-Cov‑2) Anti­gen (Sali­va) Gebrauchsanweisung.pdf
PDF-Doku­ment [2.1 MB]

Novel Coro­na­vi­rus (SARS-Cov‑2) Anti­gen Schnell­test (Spei­chel) Pres­se­mit­tei­lung (DE)
Novel Coro­na­vi­rus (SARS-Cov‑2) Anti­gen (Sali­va) Pressemitteilung.pdf
PDF-Doku­ment [127 KB]


Wond­fo SARS-CoV‑2 Anti­gen­test (Late­ral Flow Method) State­ment (EN)
Novel Coro­na­vi­rus (SARS-Cov‑2) Anti­gen (Sali­va) Statement.pdf
PDF-Doku­ment [703 KB]

Wond­fo SARS-CoV‑2 Anti­gen­test (Late­ral Flow Method) Sells­heet (EN)
Wond­fo SARS-CoV‑2 Anti­gen­test (Late­ral Flow Method) Sellsheet.pdf
PDF-Doku­ment [1 MB]

Wond­fo SARS-CoV‑2 Anti­gen­test (Late­ral Flow Method) Gebrauchs­an­wei­sung (DE)
Wond­fo SARS-CoV‑2 Anti­gen­test (Late­ral Flow Method) Gebrauchsanweisung.pdf
PDF-Doku­ment [1.1 MB]

Wond­fo SARS-CoV‑2 Anti­gen­test (Late­ral Flow Method) Decla­ra­ti­on of Noti­fi­ca­ti­on (EN)
Novel Coro­na­vi­rus (SARS-Cov‑2) Anti­gen Rapid Test (Saliva)_Declaration of Notification.pdf
PDF-Doku­ment [306 KB]

Wond­fo SARS-CoV‑2 Anti­gen­test (Late­ral Flow Method) Decla­ra­ti­on of Con­for­mi­ty (EN)
Novel Coro­na­vi­rus (SARS-Cov‑2) Anti­gen Rapid Test (Saliva)_Declaration of Conformity.pdf
PDF-Doku­ment [2 MB]

Wond­fo SARS-CoV‑2 Anti­gen­test (Late­ral Flow Method) Cli­ni­cal Eva­lua­ti­on Report (EN)
Novel Coro­na­vi­rus (SARS-Cov‑2) Anti­gen (Sali­va) Cli­ni­cal Eva­lua­ti­on Report.pdf
PDF-Doku­ment [1.3 MB]

Ver­glei­chen­de Eva­lu­ie­rung der Sen­si­ti­vi­tät von SARS-CoV‑2 Anti­gen­schnell­tests (DE)
Ver­glei­chen­de Eva­lu­ie­rung der Sen­si­ti­vi­tät von SARS-CoV‑2 Antigenschnelltests.pdf
PDF-Doku­ment [174 KB]

All­ge­mei­ne Anzei­ge­pflicht nach §§ 25 und 30 Abs. 2 MPG
DIMDI-Rapigen.pdf
PDF-Doku­ment [19 KB]

List of CE Mar­ked Pro­ducts (IVD)
Rapi­GEN List CE mar­ked pro­ducts IVD RAP.pdf
PDF-Doku­ment [136 KB]